Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis
References (28)
- et al.
Buspirone: Action on serotonin receptors in calf hippocampus
Eur. J. Pharmac.
(1983) - et al.
Buspirone: Effects on central monoaminergic transmission. Possible relevance to animal experimental and clinical findings
Eur. J. Pharmac.
(1982) Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: Measurement of catecholamines, serotonin and metabolites in rat brain
J. Neurosci. Meth.
(1981)- et al.
Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
Brain Res.
(1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptor
J. Biol. Psychiat.
(1985)- et al.
Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug
Eur. J. Pharmac.
(1986) - et al.
Buspirone: a potential atypical neuroleptic
Life Sci.
(1983) - et al.
Evidence that central 5-hydroxytryptamine neurones are involved in the anxiolytic activity of buspirone
Br. J. Pharmac.
(1989) - et al.
Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats
J. Pharmac. exp. Ther.
(1989) - et al.
Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl)piperazine, in rats
J. Pharmac. exp. Ther.
(1986)
Notes on buspirone's mechanisms of action
J. clin. Psychiat.
The comparative efficacy of buspirone and diazepam in the treatment of anxiety
Am. J. Psychiat.
The Neuropsychology of Anxiety
8-Hydroxy-2-(di-n-propylamino-tetralin, 8-OH-DPAT, a potent and selective simplified ergot cogener with central 5-HT receptor stimulating activity
J. Neural Transm.
Cited by (28)
Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats
2011, Behavioural Brain ResearchCitation Excerpt :ESCIT (10 mg/kg) and BUSP (3 mg/kg) were injected (s.c. in a volume of 1 ml/kg) daily between 8:00 and 10:00 for 20 days. These doses of ESCIT [38,51] and BUSP [26,33,63] were chosen based on previous experimental studies. A week before the actual experimental testing, all animals received 1 ml saline injection 3 times on alternating days in order to habituate to the injection procedure.
Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray
2010, Experimental NeurologyCitation Excerpt :ESCIT (10 mg/kg) and BUSP (3 mg/kg) were injected (s.c. in a volume of 1 ml/kg) 60 min and 120 min before behavioural testing, respectively. The doses of ESCIT (Lugenbiel et al., 2009; Sanchez et al., 2003) and BUSP (Kakui et al., 2009; Lim et al., 2008b; Tunnicliff et al., 1992) were chosen based on its effective pharmacological profile of previous experimental studies. A week before the actual experimental testing, all animals received 1 ml saline injection 3 times on alternating days in order to habituate the animals to the injection procedure.
Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats
2007, Pharmacology Biochemistry and BehaviorEffect of flibanserin (BIMT 17), fluoxetine, 8-OH-DPAT and buspirone on serotonin synthesis in rat brain
1999, European NeuropsychopharmacologyEffects of buspirone on an animal model of tardive dyskinesia
1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry